PrivacyInc42about 7 hours ago
Honasa Buys 58% Stake In Fluence Pharma For ₹135 Cr
4 min read
Honasa Consumer acquired a 58% stake in nutraceuticals company Fluence Pharma for ₹135 Cr, marking entry into the nutrition and supplements space. The company plans to buy the remaining 42% over 5-7 years. Honasa also formed a new subsidiary, Honasa Health, to build the vertical.
Level
Hype check
Tap to vote and see what everyone thinks.
